| Title： | Clinical Practice Guidelines for Hydrochloric Ear Disease |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis |
| Countries and regions： | China |
| Guidelines users： | The primary users of this guideline are medical professionals directly involved in the diagnosis and treatment of hydropic ear disease. This includes otolaryngologists, neurologists, rehabilitation physicians, and audiologists. These professionals will utilize the information provided in this guideline to enhance the accuracy of diagnosis and effectiveness of treatment for patients with hydropic ear disease. Additionally, educators and students at medical schools are also key users of this guideline, particularly those focusing on courses related to ear diseases and vestibular disorders. They can enhance their professional knowledge and clinical skills through this guideline. |
| Evidence classification method： | Level IV Evidence (Grade D)，Descriptive studies based on expert opinions, case reports, or clinical experiences. |
| Development unit： | Vestibular Medicine Committee of China Medicine Education Association |
| Registration time: | 2024-08-14 |
| Registration number： | PREPARE-2024CN243 |
| Purpose of the guideline: | Hydropic ear disease, commonly associated with conditions such as Ménière's disease, is characterized by symptoms like tinnitus, hearing loss, and vertigo. Given the significant impact of these symptoms on patient quality of life and the complexity of diagnosis and treatment, the purpose of this guideline is to provide medical professionals with a clear framework for diagnosis and treatment. This guideline will incorporate the latest clinical research findings and practical experiences to aid physicians in more effectively diagnosing and treating hydropic ear disease, thereby improving patient symptoms and quality of life. |
Latest registration
